Blood Screening for Influenza
Authors:
Open Access
- 1 July 2007
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (7) , 1081-1083
Abstract
Influenza viruses, including highly pathogenic avian influenza virus (H5N1), could threaten blood safety. We analyzed 10,272 blood donor samples with a minipool nucleic acid amplication technique. Analytical sensitivity of the method was 804 geq/mL and 444 geq/mL for generic influenza primers and influenza (H5N1) subtype–specific primers. This study demonstrates that such screening for influenza viruses is feasible.Keywords
This publication has 15 references indexed in Scilit:
- How prepared is Europe for pandemic influenza? Analysis of national plansThe Lancet, 2006
- Influenza Pandemics of the 20th CenturyEmerging Infectious Diseases, 2006
- Molecular characterization of the complete genome of human influenza H5N1 virus isolates from ThailandJournal of General Virology, 2005
- Probable Person-to-Person Transmission of Avian Influenza A (H5N1)New England Journal of Medicine, 2005
- Total viral genome copies and virus–Ig complexes after infection with influenza virus in the nasal secretions of immunized miceJournal of General Virology, 2004
- NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissionsTransfusion, 2004
- Harmonisation of national influenza surveillance morbidity data from EISS: a simple indexEurosurveillance, 2003
- Yield of HCV and HIV‐1 NAT after screening of 3.6 million blood donations in central EuropeTransfusion, 2002
- Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank settingThe Lancet, 1999
- Safety of the Blood Supply in the United States: Opportunities and ControversiesAnnals of Internal Medicine, 1997